As an internationally recognized clinical investigator, Dr. Nichols’ current research focuses on improving treatments for patients with inherited bleeding disorders. His expertise in vascular biology research focuses on the role of von Willebrand factor in arterial thrombosis. Dr. Nichols also has an active hemostasis research program to develop new therapies for hemophilia A and hemophilia B, especially those complicated by inhibitory antibodies (anti-drug antibodies).
Dr. Nichols’ other special interests include coronary artery disease and thrombosis, cardiac catheterization, coronary angioplasty, and novel ultrasound imaging techniques.